Naltrexone Quieted Threat Signals Without Hurting Reappraisal

Naltrexone Quieted Threat Signals Without Hurting Reappraisal

TL;DR: A 2026 study in The British Journal of Psychiatry found that a single 50 mg dose of naltrexone reduced distress and shifted threat-related brain activity without blocking people’s ability to reappraise negative images. Key Findings 38 healthy volunteers completed a placebo-controlled crossover: Participants received naltrexone 50 mg and placebo on separate visits, then performed …

Read more

New PTSD Treatments: Drugs in Development & Pharmacological Targets

Post-traumatic stress disorder (PTSD) continues to afflict millions worldwide, necessitating more effective therapeutic options. Key Facts: PTSD involves dysfunctional fear processing and altered threat perception. Current treatments fail to comprehensively address its complex symptoms. Research implicates dysregulation in brain systems like the HPA axis and glutamate, presenting novel drug targets. Medications modulating oxytocin, cannabinoids, opioids …

Read more